NexLife announces a new report, the October 2026 NexLife GLP-1 Price Index, on the monthly prices of compounded tirzepatide ...

Biomea Fusion, Inc. (“Biomea” or the “Company”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company, today announced ...

HEALDSBURG, CA / ACCESS Newswire / October 12, 2026 / ISOThrive Inc. today announced final results from its Phase 2 trial of ...

Shenzhen Chipscreen Biosciences Co., Ltd. (“Chipscreen Biosciences” or the “Company”)(SSE: 688321) announced that the China ...

ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global ...

(Nasdaq: TVTX) today announced that on October 10, 2026, the Compensation Committee of its Board of Directors granted ...

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today ...

Syndax Pharmaceuticals (Nasdaq: SNDX) today announced that the MAXPIRe Phase 2 trial of axatilimab in idiopathic pulmonary ...

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that it will host an R&D Day on Wednesday, November ...

Additional Analyses from ACACIA-HCM Further Characterize Exercise Performance, Treatment Effect, Dose Titration and Safety of ...

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2026 financial results on ...

Xodus Medical, a leading developer and manufacturer of innovative surgical safety solutions, today announced that it has ...